Trastuzumab Completed Phase 3 Trials for Tubular Breast Cancer Stage II / Invasive Ductal Breast Carcinoma / Tubular Breast Cancer Stage III / Mucinous Breast Cancer Stage II / HER2 Positive Breast Cancers / Malignant Neoplasm of Female Breast / Inflammatory carcinoma of the breast Treatment